profit from every A$100 of sales.
A$0A$100
Sigma Healthcare
A$2.89+0.00% today
-1.0% in 1 year
1-year low A$2.501-year high A$3.16
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay A$62.96 for every A$1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Sigma Healthcare vs. similar companies
Sigma Healthcare grows the fastest of these 5 and is the most expensive for its profits.
| Company | Profit from A$100 of sales | Sales growth a year | Price per A$1 of profit |
|---|---|---|---|
| Sigma Healthcare | 63.0× · Very expensive | ||
 McKesson | 26.7× · Fair price | ||
 Cencora | 44.1× · Expensive | ||
 Cardinal Health | 41.6× · Expensive | ||
 Henry Schein | 23.9× · Fair price |
AI analysis
An AI analyst reads Sigma Healthcare's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 63.0×
- –
- 0.31
- 6.6×
- 5.6×
- 61.6×
- –
- 1.6%
- 1.6%
- –
Profitability
- 24.0%
- 11.1%
- 8.8%
- –
- 8.1%
- 3.5%
- –
- –
- –
- –
Growth
- +17.9%
- +205.5%
- –
- –
- +117.3%
Financial health
- 2.3×
- 0.44
- –
- 23.5×
- 1.71
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 40%of 963
Top 48%of 894
Bottom 18%of 632
Top 30%of 908
Top 48%of 991
News
Sigma Lithium outlines 330,000 tons 2027 production plan backed by $125M 5-year convertible noteSeeking Alpha · Nov 13, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
40No pass
Benjamin Graham
21No pass
Philip Fisher
37No pass
Peter Lynch
71Pass
Joel Greenblatt
5No pass
Charlie Munger
32No pass
Terry Smith
33No pass
Questions about Sigma Healthcare
Is Sigma Healthcare a good stock to buy?
A solid business, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Sigma Healthcare AI analysis
What does Sigma Healthcare do?
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It is in Medical Distribution, based in Clayton, VIC, Australia.
Is Sigma Healthcare stock halal?
Yes. Sigma Healthcare passes our halal screen: its business is permitted and its debt is 6% of its market value, under the 30% limit. How we check
How has Sigma Healthcare stock done over the past year?
Down 1.0% over the past twelve months, to A$2.89. It traded between A$2.50 and A$3.16 and is 8.5% below its high.
Who are Sigma Healthcare's competitors?
The largest listed companies in the same industry are McKesson, Cencora, Cardinal Health and Henry Schein. The peers table on this page compares their profit, growth and price with Sigma Healthcare's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.